Extracorporeal Membrane Oxygenation Retrieval in Coronavirus Disease 2019: A Case-Series of 19 Patients Supported at a High-Volume Extracorporeal Membrane Oxygenation Center.
coronavirus
coronavirus disease 2019
extracorporeal membrane oxygenation
extracorporeal membrane oxygenation retrieval
extracorporeal membrane oxygenation transport
severe acute respiratory syndrome coronavirus 2
Journal
Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
17
10
2020
Statut:
epublish
Résumé
To evaluate the performance of the extracorporeal membrane oxygenation retrieval team at a high-volume extracorporeal membrane oxygenation center during the coronavirus disease 2019 pandemic. Observational study including all adult patients with confirmed infection due to severe acute respiratory syndrome coronavirus-2 cannulated at other centers and transported on extracorporeal membrane oxygenation to the ICU of the Vall d'Hebron University Hospital between 15 March and 10 June 2020. The ICU (capacity expanded to 200 during the pandemic) of the Vall d'Hebron University Hospital (a 1,100-bed public university hospital in Barcelona), the referral center for extracorporeal respiratory support in Catalonia (7.5 million inhabitants). Extracorporeal membrane oxygenation was considered if the Pao Venovenous extracorporeal membrane oxygenation was initiated in the primary center. Then, patients were transferred to the ICU of the Vall d'Hebron University Hospital where they received support until respiratory improvement. After decannulation, patients were discharged for rehabilitation at the primary center. Nineteen patients with severe acute respiratory syndrome coronavirus-2 infection and with a mean Pao Extracorporeal membrane oxygenation retrieval can rescue young, previously healthy patients with severe coronavirus disease 2019 in whom all the conventional respiratory measures have failed. Thrombotic and hemorrhagic complications are frequent in this cohort.
Identifiants
pubmed: 33063032
doi: 10.1097/CCE.0000000000000228
pmc: PMC7523810
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0228Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Déclaration de conflit d'intérêts
The authors have disclosed that they do not have any potential conflicts of interest.
Références
ASAIO J. 2020 Jul;66(7):722-730
pubmed: 32317557
Intensive Care Med. 2018 Nov;44(11):1914-1922
pubmed: 30291378
Crit Care. 2020 Apr 15;24(1):148
pubmed: 32293518
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901
pubmed: 25695688
ASAIO J. 2020 May;66(5):475-481
pubmed: 32243266
Am J Respir Crit Care Med. 2020 Aug 1;202(3):460-463
pubmed: 32543208
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075
J Crit Care. 2020 Aug;58:27-28
pubmed: 32279018
Crit Care. 2020 May 8;24(1):205
pubmed: 32384917
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Crit Care Med. 2020 Sep;48(9):1289-1295
pubmed: 32427613